SCHEMBL2145602

SCHEMBL2145602

Cc1ccc(S(=O)(=O)OCCCCl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.46
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46
ALDH1A1 P00352 4/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
CA2 P00918 2/20 0.42
GAA P10253 1/20 0.42
PSMD10 O75832 1/20 0.42
STAT3 P40763 1/20 0.41
CYP24A1 Q07973 2/20 0.41
G6PD P11413 1/20 0.41
KMT2A Q03164 1/20 0.41
CA3 P07451 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
VDR P11473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9240104 0.95 CA1 (0.45) CA1CA12CA9ALDH1A1CYP3A4
SCHEMBL8970343 0.93 CA12 (0.44) CA1CA12CA9ALDH1A1CYP3A4
SCHEMBL7645036 0.93 CA12 (0.44) CA1CA12CA9ALDH1A1CYP3A4
SCHEMBL10673660 0.93 CA12 (0.44) CA1CA12CA9ALDH1A1CYP3A4
SCHEMBL5057127 0.93 CA12 (0.44) CA1CA12CA9ALDH1A1CYP3A4
SCHEMBL10670985 0.93 CA12 (0.44) CA1CA12CA9ALDH1A1CYP3A4
SCHEMBL3236370 0.93 CA12 (0.44) CA1CA12CA9ALDH1A1CYP3A4
SCHEMBL10672617 0.93 CA12 (0.44) CA1CA12CA9ALDH1A1CYP3A4
SCHEMBL9725187 0.93 CA12 (0.44) CA1CA12CA9ALDH1A1CYP3A4
SCHEMBL263231 0.89 GAA (0.45) CA1CA12CA9ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118755421-B Preparation process of durable adhesive and durable self-adhesive label material 江苏金大包装材料科技有限公司 2024-11-15 CN claimed
CN-118755421-A Preparation process of durable adhesive and durable self-adhesive label material 江苏金大包装材料科技有限公司 2024-10-11 CN claimed
US-20080039613-A1 Process for the Production of Azidoalkylamines DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) 2008-02-14 US claimed
EP-1735272-A1 METHOD FOR PRODUCING AZIDOALKYL AMINES Dynamit Nobel Gmbh (DE) 2006-12-27 EP claimed
WO-2005097736-A1 METHOD FOR PRODUCING AZIDOALKYL AMINES DYNAMIT NOBEL GMBH (DE) 2005-10-20 WO claimed
US-20250360108-A1 CATALYTIC INHIBITOR OF PROTEIN PHOSPHATASE 5 ACTIVATES THE EXTRINSIC APOPTOTIC PATHWAY BY DISRUPTING COMPLEX II UNIV NEW YORK STATE RES FOUND (US) 2025-11-27 US disclosed
CN-118755421-B Preparation process of durable adhesive and durable self-adhesive label material 江苏金大包装材料科技有限公司 2024-11-15 CN disclosed
CN-118755421-B Preparation process of durable adhesive and durable self-adhesive label material 江苏金大包装材料科技有限公司 2024-11-15 CN disclosed
CN-118755421-A Preparation process of durable adhesive and durable self-adhesive label material 江苏金大包装材料科技有限公司 2024-10-11 CN disclosed
CN-118755421-A Preparation process of durable adhesive and durable self-adhesive label material 江苏金大包装材料科技有限公司 2024-10-11 CN disclosed
WO-2024167922-A2 HETEROCYCLIC COMPOUNDS AS NRAS INHIBITORS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-08-15 WO disclosed
WO-2023244531-A1 CATALYTIC INHIBITOR OF PROTEIN PHOSPHATASE 5 ACTIVATES THE EXTRINSIC APOPTOTIC PATHWAY BY DISRUPTING COMPLEX II THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2023-12-21 WO disclosed
EP-0478363-A2 Novel sulfonamide fibrinogen receptor antagonists MERCK & CO. INC. (US) 1992-04-01 EP disclosed
US-4985590-A Optically active benzene derivatives and process for preparation thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-01-15 US disclosed
US-4853408-A 4-phenylpropyl-indoles having antiarythmic activity ROUSSEL UCLAF (FR) 1989-08-01 US disclosed
EP-0188333-B1 ANTI-INFLAMMATORY GUANIDINES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM SYNTEX (U.S.A.) INC. (US) 1989-07-19 EP disclosed
US-4792570-A 3- and 4-biphenyloxyaminoalkanes and related compounds as anti-inflammatory and analgetic agents SYNTEX (U.S.A.) INC. (US) 1988-12-20 US disclosed
US-4680300-A PSORIASIS SYNTEX (U.S.A.) INC. (US) 1987-07-14 US disclosed
EP-0188333-A1 Anti-inflammatory guanidines, their preparation and compositions containing them SYNTEX (U.S.A.) INC. (US) 1986-07-23 EP disclosed
EP-0157652-A1 2-, 3- And 4-biphenyloxyaminoalkanes and related compounds, their preparation and uses, and pharmaceutical compositions containing them SYNTEX (U.S.A.) INC. (US) 1985-10-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039613-A1 Process for the Production of Azidoalkylamines UNG, ALKBH1, ALKBH2 CA1 3349/4885CA12 2410/4885CA9 2672/4885
US-20250360108-A1 CATALYTIC INHIBITOR OF PROTEIN PHOSPHATASE 5 ACTIVATES THE EXTRINSIC APOPTOTIC PATHWAY BY DISRUPTING COMPLEX II PPP5C, VHL, PPP2R5A CA1 3306/4885CA12 3461/4885CA9 2443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.